MÁster en estudios biológico-naturistas y homeopatíA
descargar 0.58 Mb.
|
Visión Biológica de la Disfunción Orgánica. (7 créditos, 70 horas, 6 semanas) Objetivos
Bibliografía [1] "Metas nutricionales". Archivos Latinoamericanos de Nutrición. Vol. 38; pp. 384-415. 1998. [2] "System ISI calibration: a universally applicable scheme is posible only when coumarin plasma calibrants are used". British Journal of Haematology. Vol. 96; pp. 435-441. 1997. [3] "Use of plasma from donors under oral anticoagulante treatment for the expression of INR values". Haematologica. N°5; vol. 82; pp. 630-633. 1997. [4] ABRAHAM, G. "Management of fibromyalgia: rationale for the use of magnesium and malic acid". J Nutr Med. Vol. 3; pp. 49-59. 1992. [5] AD HOC COMMITEE OF THE WORKING GROUP ON VALVULAR HEART DISEASE, EUROPEAN SOCIETY OF CARDIOLOGY. "Guidelines for prevention of tromboembolic events in valvular heart disease". The Journal of Heart Valve Disease. Vol. 2; pp. 398-410. [6] AHFS. "Drugs information". pp. 1157-1163. 1998. [7] AIDLEY, D.J. "The physiology of excitable cells" (4ª ed.). Cambridge University Press. Cambridge. 1998. [8] AKMAN-DEMIR, F.G.; ERAKSOY, M.; GURVIT, I.H.; SARUHAN-DIRESKENELI, G.; ARAL, O. "Paroxysmal dysarthria and ataxia in a patient with behç et's disease". Journal of Neurology. Vol. 242; pp. 344-347. 1995. [9] ALARCÓN, J.A.; ADEINO, F.J. "Diferencias urbano-rurales en la ingesta de alimentos de familias pobres de Guatemala". Archivos Latinoamericanos de Nutrición. Vol. 41; pp. 325-335. 1991. [10] ALCALÁ, A.; FERNÁNDEZ, O. "Alteraciones neuroftalmológicas". En: FERNÁNDEZ, O. (ed.). "Esclerosis múltiple. Una aproximación multidisciplinaria". Asociación Española de Esclerosis múltiple (AEDEM). pp. 359-396. Barcelona. 1994. [11] ALFREY, A. C. "Trace metals". En: EKNOYAN, G.; KNOCHEL, J.P. "The systemic consequence of renal disease". Orlando. 1984. [12] ALLEN, L.H.; WOOD, R. "Calcium and phosphorus". En: SHILIS, M.E.; OLSON, J.A.; SHIKE, M. "Modern nutrition in health and disease". Lea & Febuger. pp. 144-163. Filadelfia. 1994. [13] ALMADEN, Y.; CANALEJO, A.; HERNANDEZ, A.; BALLESTEROS, E.; GARCIA-NAVARRO, S.; TORRES, A.; RODRIGUEZ, M. "Direct effect of phosphorus on parathyroid hormone secretion from whole parathyroid glands in vitro". Journal of Bone and Mineral Research: the official journal of the American Society for Bone and Mineral Research. Vol. 11; pp. 970-976. 1996. [14] AMIAN, A.; RODRÍGUEZ, J.N.; MUÑIZ, R.; DIÉGUEZ, J.C.; CAÑAVATE, M.; FERNÁNDEZ, A. et al. "Tratamiento con anticoagulantes orales (acenocumarol): influencia de la dosis inicial en la incidencia de episodios hemorrágicos y tromboembólicos". Revista Sangre. N°6; vol. 39; pp. 413-416. Costa Rica. [15] ANDREW, K.S.; VICENT, L.M.; ESNAUL, T.C.; LOCKWOOD, M. "Anti-neutrophil cytoplasm antibodies and anti-glomerular basement antibodies: two coexisting dictinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis". American Journal of Kidney Diseases: the official journal of the National Kidney Foundation. Vol. 26; pp. 439-45. 1995. [16] ANÓNIMO. "Sales anónicas en dietas preparto". Nutrición Animal Aplicada. Año V; N° 27; pp. 32-40. Buenos Aires. 1993. [17] ANONIMO. "Hipolipemiantes de elección". The Medical Letter (Edición Española). N°19; pp. 77-80. España. 1996. [18] ANONIMO. "Hyperlipidaemia: when should treatment be initiated?". Drugs Ther Perspect. N°9; pp. 7-13. 1997. [19] ANTHONY, R.; HUBBARD, S.M.L.; BARROWCLIFFE, W. "International normalized ratio determination using calibrated reference plasmas". British Journal of Haematology. Vol. 98; pp.74-78. 1997. [20] ARBIZU, T.; MIRÓ, J.; FERNÁNDEZ-URÍA, D.; HERNÁNDEZ, M.A. "Clínica". En: FERNÁNDEZ, O. (ed.). "Esclerosis múltiple. Una aproximación multidisciplinaria". Asociación Española de Esclerosis múltiple (AEDEM). pp. 175-221. Barcelona. 1994. [21] ASSOCIATION OF OFFICIAL AGRICULTURAL CHEMISTS. "Official methods of analysis of the association official agricultural chemist". AOAC. Washington D.C. 1995. [22] ATTIAS, J. et al. "Oral magnesium intake reduces permanent hearing loss induced by noise exposure". American Journal of Otolaryngology. Vol. 15; pp. 26-32. 1994. [23] AUTHEMENT, J.M. "Blood transfusion therapy". En: DIBARTOLA, S.P. "Fluid therapy in small animal practice". WB Saunders. pp. 371-383. Filadelfia. 1992. [24] AVIOLI, L.V. "Calcium and phosphorus". En: SHILIS, M.E.; YOUNG, V.R. (ed.). "Modern nutrition in health and disease". Lea & Febige. pp. 124-158. Filadelfia. 1998. [25] AZARI, J. et al. "Taurine decreases lesion severity in the hearts of cardioomyophatic hamsters". The Canadian Journal of Neurological Sciences. Vol. 7; p. 435. 1980. [26] AZUMA, J. et al. "Double-blind randomized crossover trial of taurine in congestive heart failure". Current Therapeutic Research, Clinical and Experimental. Vol. 34; p. 543. 1983. [27] AZUMA, J. et al. "Taurine for treatment of congestive heart failure". The American Journal of Cardiology. Vol. 2; pp. 303-304. [28] BAJO, M.A.; SELGAS, R.; POSSANTE, C.; AGUILERA, A.; SÁNCHEZ, C.; DÍAZ, C. et al. "Frequent recurrence of secundary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients. Advances in peritoneal dialysis". Conference on Peritoneal Dialysis. Vol. 13; pp. 239-243. 1997. [29] BARBEAU, A. et al. "Zinc, taurine, and epilepsy". Archives of Neurology. Vol. 30; pp. 52-58. 1974. [30] BEEDE, D.K. "The DCAD concept: Transition rations for dry pregnant cows". Feedstuffs. N°5; vol. 64; p. 12. 28 de diciembre de 1992. [31] BELLI, D.C. et al. "Taurine improves the absorption of a fat meal in patients with cystic fibrosis". Pedriatrics. Vol. 80; pp. 517-523. 1987. [32] BENVENISTE, H.; DREJER, J.; SCHOUSBOE, A.; DIEMER N.H. "Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdíalysis". Journal of Neurochemistry. Vol. 43; pp. 1369-1374. 1984. [33] BERRETTINI, M. "Anticoagulation clinics: the italian experience". Haematologica. N°6; vol. 82; pp. 713-717. 1997. [34] BLOCK, E. "Manipulating dietary anions and cations for prepartum dairy cows to reduce incidence of milk fever". Journal of Dairy Science. Vol. 67; pp. 2939-2948. 1984. [35] BLOCK, E. "Manipulation of dietary cation-anion difference on nutritionally related production diseases, productivity and metabolic responses of dairy cows". Journal of Dairy Science. Vol. 77; pp. 1437-1450. 1994. [36] BOSCH, X.; MIARPEIX, E.; FONT, J.; CERVERA, R.; INGELMO, M.; KHAMASTHA, M.A. et al. "Anti-mieloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaris". American Journal of Kidney Diseases: the official journal of the National Kidney Foundation. Vol. 20; pp. 231-239. 1992. [37] BOSSE, G.M. "Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation". Journal of Toxicology. Clinical Toxicology. Vol. 32; pp. 233-241. 1994. [38] BOX, G. "Estadística para investigadores, introducción al diseño de experimentos, análisis de datos y construcción de modelos". Editorial Reverté. Barcelona. 1998. [39] BREVES, G.; GOFF, J.P.; SCHRODER, B.; HORST, R.L. "Gastrointestinal calcium and phosphate metabolism in ruminants". En: ENGELHARDT, Von; et. al. "Proc. 8th. International Symposium on Ruminant Physiology". 1995. [40] BRITISH NATIONAL FORMULARY. "The pharmaceutical press". N°32; pp. 170-172. Londres. Septiembre de 1996. [41] BROADUS, A.E. "Physiologic functios of calcium, magnesium, and phosphorus". En: J.F.M. (ed.). "Primer metabolic bone disease and disorders or mineral metabolism". American Society for Bone and Mineral Research. pp. 29-30. California. 1990. [42] BRYANT, S.H. "Ion channels as targets for genetic disease". En: SPERELAKIS, N. (ed.). "Cell physiology: source book" (2ª ed.). Academic Press. pp. 574-594. San Diego. 1998. [43] BULL, R.W. "Inmunohematología". En: HALLIWELL, R.E.W.; GORMAN, N.T. "Inmunología Clínica Veterinaria". Editorial Acribia. pp. 499-505. Zaragoza. 1992. [44] CADELL, J.L. "Geriatric cachexia: a role for magnesium deficiency as well as for cytokines?". American Journal of Clinical Nutrition. N°3; vol. 71; pp. 851-853. 2000. [45] CAMPISTOL, J. "Avances en neurología neonatal". Revista de Neurología. Vol. 31; pp. 601-604. 2000. [46] CHABANNE, L.; PEYRONNET, L.; FOURNEL, C.; MEYER, F.; RIGAL, D. "Les groupes sanguins des carnivores domestiques. Transfusion et maladies hémolytiques néonatales". Point Vet. N°157; vol. 25; pp. 819-832. 1994. [47] CHEN ZHUO, L.; MURUBE, J.; LATORRE, A.; MARTÍN DEL RÍO, R. "Investigación". Archivos de la Sociedad Canaria de Oftalmología. N° 11. Gran Canaria. 2000. [48] CHOI, D.W. "Cerebral hypoxia: some new approaches and unanswered questions". The Journal of Neuroscience: the official journal of the Society for Neuroscience. Vol. 10; pp. 2493-2501. 1990. [49] CHOI, D.W.; MAULUCCI-GEDDE, M.; KRIEGSTEIN, A.R. "Glutamate neurotoxicity in cortical cell culture". The Journal of Neuroscience: the official journal of the Society for Neuroscience. Vol. 7; pp. 357-368. 1987. [50] COHEN, L.; KITZES, R. "Infrared spectroscopy and magnesium content of bone mineral in osteoporotic women". Israel Journal of Medical Sciences. Vol. 17; pp. 1123-1125. 1981. [51] CORDERO, L.; LANDON, M.B. "Infant of the díabetics mother". Clinics in Perinatology. Vol. 3; p. 625. 1998. [52] CORNBLATH, M. et al. "Hipoglycemia in the neonate". The Journal of Pediatric Endocrinology. Vol. 6; pp. 113-129. 1996. [53] COTMAN, C.W.; PETERSON, C.H. "Aging in the nervous system". En: SIEGEL, G.; AGRANOFF, B.; ALVERS, R.W.; MOLINOFF, P. (ed.). "Basic neurochemistry" (4ª ed.). Raven Press. Nueva York. 1989. [54] COX, I.M.; CAMPBELL, M.J.; DOWSON, D. "Red blood cell magnesium and chronic fatigue syndrome". Lancet. N°8744; vol. 337; pp. 757-760. 1991. [55] COYLE, J.T.; BIRD, S.J.; EVANS, R.H. et al. "Excitatory amino acids neurotoxins: selectivity, specificity and mechanisms of action". Neurosciences Research Program Bulletin. Vol. 19; p. 331. 1981. [56] CRUMRINE, R.C.; LAMANNA, J.C. "Regional cerebral metabolites, blood flow, plasma volume and mean transit time in total cerebral ischemia in the rat". Journal of Cerebral Blood Flow and Metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. Vol. 11; pp. 272-282. 1991. [57] DAVIS, F.A.; BECKER, F. O.; MICHAEL, J. A.; SORENSEN, E. "Effect of intravenous sodium bicarbonate disodium edetate and hyperventilation on visual and oculomotor signs in multiple sclerosis". Journal of Neurology, Neurosurgery, and Psychiatry. Vol. 33; pp. 723-732. 1970. [58] DENDA, M.; FINCH, J.; SLATOPOLSKY, E. "Parathyroid hyperplasia and secondary hyperpara-thyroidism develop rapidLy in experimental uremic rats". Journal of Bone and Mineral Research: the official journal of the American Society for Bone and Mineral Research. Vol. 10; p. 276. 1995. [59] DÍAZ, A.; GUINZBERG, P.R.; URIBE, S.; PIÑA, E. "Metabolic responses of isolated hepatocytes to adenosine; dependence on oxternal calcium". Life Sciences. Vol. 49; pp. 505-510. 1991. [60] DJURHUUS, M.S.; SKOTT, P.; HOTHER, N.O. "Insulin increases renal magnesium excretion: a possible cause of magnesium depletion in hyperinsulinaemic states". Diabetic Medicine: a journal of the British Diabetic Association. Vol. 12; pp. 664-669. 1995. [61] DOMÉNECH, E.; CASTRO, J.R. "Síndrome de sufrimiento cerebral neonatal". En: CRUZ, M. "Tratado de pediatría" (8ª ed.). Editorial Ergón. Madrid. 2001. [62] DORVIL, N.P. et al. "Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs". The American Journal of Clinical Nutrition. Vol. 37; pp. 221-232. 1983. [63] DUEÑAS, A. "Intoxicaciones agudas en medicina de urgencia y cuidados críticos". Editorial Masson. Barcelona. 1999. [64] DUKES, H.H.; SWENSON, M.J. "Fisiología de los Animales Domésticos". Ed. Aguilar. Madrid. 1977. [65] DUSSO, A.S.; PAVLOPOULOS, T.; NAUMOVICH, L.; LU, Y.; FINCH, J.; BROWN, A. J. et al. "p21 waf1 and transforming growth factor alfa medíate dietary phosphate regulation of parathyroid cell growth". Kidney International. Vol. 59; pp. 853-865. [66] ERNST, A.; ZIBRAK, J.D. "Carbon monoxide poisoning". The New England Journal of Medicine. Vol. 339; pp. 1603-1608. Inglaterra. 1998. [67] ESPIR, M.L.E.; WATKIN, S.M.; SMITH, H.V. "Paroxysmal disarthria and other transient neurological disturbances in disseminated sclerosis". Journal of Neurology, Neurosurgery, and Psychiatry. Vol. 299; pp. 323-330. 1966. [68] EUROPEAN ATRIAL FIBRILLATION TRIAL STUDY GROUP. "Secondary prevention in non.rheumatic atrial fibrillation after transient ischaemic attack or minor stroke". Lancet. Vol. 342; pp. 1255-1256. 1993. [69] FERRIBI, M.A. "Foods habits and the apparent nature and extent of dietary nutritional deficiencies in the Peruvian Andes". Archivos Latinoamericanos de Nutrición. pp. 850-866. 1982. [70] FLANAGAN, R.J.; RUPRAH, M.; MEREDITH, T.J. et al. "An introduction to the clinical toxicology of volatile substances". Drug Safety. Vol. 5; pp. 359-383. 1990. [71] FLECKENSTEIN, A. "Der kalium-natrium austausch". Als energieprinzip in muskel und nerv. Springer-Verlag. Berlín, Heidelberg. 1955. [72] FLORES, M.; ARANDA-PASTOR, J. "Evaluación a nivel nacional en Costa Rica: cambios en una década". Archivos Latinoamericanos de Nutrición. Vol. 30; pp. 432-450. 1980. [73] FLYNN, C.J.; FAROOQUI, A.A.; HORROCKS, L.A. "Ischemia and hypoxia". En: SIEGEL, G.; AGRANOFF, B.; ALVERS, R.W.; MOLINOFF, P. (ed.). "Basic neurochemistry" (4ª ed.). Raven Press. Nueva York. 1989. [74] FORBES, G.B. "Calcium accumulation by the human fetus". Pedíatrics. Vol. 57; pp. 976-977. 1976. [75] FRANCONI, F. et al. "Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation". The American Journal of Clinical Nutrition. Vol. 61; pp. 1115-1119. 1995. [76] FREDEEN, A.H.; DEPETERS, E.J.; BALWIN, R.L. "Characterization of acid-base disturbances and effects on calcium and phosphorus balances of dietary fixed ions in pregnant and lactating does". Journal of Animal Science. Vol. 66; pp. 159-173. 1988. [77] FREDEEN, A.H.; DEPETERS, E.J.; BALDWIN, R.L. "Effects of acid-base disturbances caused by differences in dietary fixed ion balance on kinetics of calcium metabolism in ruminants with high calcium demand". Journal of Animal Science. Vol. 66; pp. 174-184. 1988. [78] FREEMAN, A.R.; SPIRTES, M.A. "A rapid and simple method for the determination of intracellular sodium and potassium in the mamalian erythrocyte". Clinica Chimica Acta; International Journal of Clinical Chemistry. Vol. 8; pp. 641. 1963. [79] GARABENDÍAN, M. "Physiologie du métabolisme phosphocalcique et besoins en calcium, phosphore et vitamine de chezl'enfant". En: GARABEDÍAN, M.; DAVID, L.; DUMAS, R.; MALLET, E. (ed.). "Metabolisme phosphocalcique normal er pathologique chez l'enfant". Flammarion Médecine-Science. pp. 1-11. París. 1993. [80] GARDNER, K.; BARMADA, M.M.; PTACEK, L.J. et al. "A new locus for hemiplegic migraine maps to chromosome 1q31". Neurology. Vol. 49; pp. 1231-1238. 1997. [81] GARRAHAN, P. et al. "Sodium exchange distribution in the arterial wall". The American Journal of Physiology. Vol. 209; p. 9559. 1965. [82] GASPAR, A.Z.; GASSER, P.; FLAMMER, J. "The influence of magnesium on visual field and peripheral vasospasm in glaucoma". Ophthalmologica. Vol. 209; pp. 11-13. 1995. [83] GAY, C.C.; BESSER, T.E. "Colostrum and feeding management of the dairy calf during the first two days of life". En: NAYLOR, J.M.; RALSTON, S.L. (ed.). "Large animal clinical nutrition". Mosby-Year Book, Inc. St. Louis, Missouri. 1991. [84] GAYNOR, P.J. et al. "Parturient hypocalcemia in jersey cows fed alfalfa haylage-based diets with different cation to anion ratios". Journal of Dairy Science. Vol. 72; pp. 2525-2531. 1989. [85] GEGGEL, H.S. et al. "Nutritional requirement for taurine in patients receiving long-term parenteral nutrition". The New England Journal of Medicine. Vol. 312; pp. 142-146. 1985. [86] GESSLER, U. "Intra und extracelluláre elektrolitveränderungen bei essentieller hypertonie vor und nach behandiung". Untersuchungen an erythrozyte. Z. Kreislauforschung 51B; p. 177. 1962. [87] GIGER, U. "El sistema del grupo sanguíneo AB felino y reacciones de hiscompatibilidad". En: KIRK, R.W.; BONAGURA, J.D. (ed.). "Terapéutica veterinaria de pequeños animales XI". Interamericana McGraw-Hill. pp. 519-525. Madrid. 1994. [88] GILES, C.L. "Peripheral uveitis in patients with multiple sclerosis". American Journal of Ophthalmology. Vol. 70; pp. 17. 1970. [89] GOA, K.L.; BARRADELL, L. B.; PLOSKER, G. L. "Bezafibrate: and update of its pharmacology and use in the management of dyslipidaemia". Drugs. N°5; Vol. 52; pp. 725-753. 1991. [90] GOFF, J.P. "Cation-Anion difference of diets and its influence on milk fever and subsequent lactation: the good and the bad news". Cornell Nutrition Conference for Feed Manufacturers. Cornell University. Ithaca, NY. 1992. [91] GOFF, J.P.; HORST, R.L. "Calcium salts for treating hypocalcemia: carrier effects, acid base balance and oral versus rectal administration". Journal of Dairy Science. Vol. 77; pp. 1451-1456. 1994. [92] GOFF, J.P.; REINHARDT, T.A., HORST, R.L. "Milk fever and dietary cation-anion balance effects on concentration of vitamin D receptor in tissu e of periparturient dairy cows". Journal of Dairy Science. Vol. 78; pp. 2388-2394. 1995. [93] GREER, F. R. "Disorders of calcium homeostasis". En: SPITZER, A.R. (ed.). "Intensive care of the fetus and neonate". Ed. Mosby. San Luis, California. 1996. [94] GUINZBERG, P.R.; DÍAZ, A.; URIBE, S.; PIÑA, E. "Inhibition of adenosine medíated responnses in isolated hepatocytes by depolarizing concentrations of K+". Biochemical and Biophysical Research Communications. Vol. 197; pp. 229-234. 1993. [95] GUINZBERG, P.R.; LAGUNA, I.; ZENTELLA, A.; GUZMÁN, R.; PIÑA, E. "Effect of adenosine and inosine on ureagenesis in hepatocytes". The Biochemical Journal. Vol. 245; pp. 371-374. 1987. [96] HACKE, W.; HENERICI, M.; GELMERS, H.J.; KRAMER, G. "Cerebral ischemia". Springer-Verlag. Berlín. 1991. [97] HALL, D.E.; PAZARA, K.E.; LINSEMAN, K.L. "Sex differences in postischemia neuronal necrosis in gerbils". Journal of Cerebral Blood Flow and Metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. Vol. 11; pp. 292-298. 1991. [98] HANSEN, A.J.; MUTCH, W.A.C. "Water and ions fluxes in cerebral ischemia". En: BES, A.; BRAQUET, P.; PAOLETTI, R.; SESJO, B.K. (ed.). "Cerebral ischemia". Excerpta Medica. Amsterdam. 1984. [99] HAYES, K.C. et al. "Retinal degeneration associated with taurine deficiency in the cat". Science. Vol. 188; pp. 949-951. 1975. [100] HEANEY, R.P.; SMITH, K.T.; RECKER, R.R.; HINDERS, S.M. "Meal effects on calcium absorption". American Journal of Clinical Nutrition. Vol. 49; pp. 372-376. 1989. [101] HEINBACH, D.M.; WAEKERLE, J.F. "Inhalation injuries". Annals of Emergency Medicine. N°12; vol. 17; pp. 1316-1320. 1988. [102] HELLMARK, T.; NILES, J.L.; COLLINS, B.; MCCLUSKEY, R.T.; BRUNMARK, C. "Comparison of anti-GBM antibodies in sera with or without ANCA". Journal of the American Society of Nephrology: JASN. Vol. 8; pp. 376-85. 1997. [103] HINSBERG, K.; LANG, K. "Medizinische chemie für de klinischen und theoretischen gebrauch". Urban & Schwarzenberg. Berlín. 1957. [104] HORST, R.L. "Regulation of calcium and phosphorus homeostasis in the dairy cow". Journal of Dairy Science. Vol. 69; pp. 604-616. 1986. [105] HOSSMANN, K.A. "Treatment of experimental cerebral ischemia". Journal of Cerebral Blood Flow and Metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. Vol. 2; pp. 275-284. 1982. [106] HOSSMANN, K.A. "Post-ischemic resucitation of the brain: selectivity neuronal vulnerability versus global resistance". En: KOGURE, K.; HOSSMANN, K.A.; SIESJÖ, B.K.; WELSH, F.A. (ed.). "Molecular mechanisms of brain damage, progress in brain research". Ed. Elsevier. Vol. 63. Amsterdam. 1985. [107] HOSSMANN, K.A.; KLEIHVES, P. "Reversibility of ischemia brain damage". Archives of Neurology. Vol. 29; pp. 375-384. 1973. [108] HOVE, K. "Cyclic changes in plasma calcium and the calcium homeostatic endocrine system of the postparturient dairy cow". Journal of Dairy Science. Vol. 69; pp. 2072-2082. 1986. [109] HULL, R.D.; RASKOB, G.E.; ROSEMBLOOM, D. "Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis". The New England Journal of Medicine. Vol. 322; pp. 1260-12649. 1990. [110] HURSE, M.L. "Warfarin resistence: díagnosis and therapeutic alternatives". Pharmacotherapy. N° 6; vol. 16; pp. 1009-1017. 1996. [111] HUTCHISON, A.L.; GOKAL, R. "Calcium, phosphate and renal ostodystrophy". En: GOKAL, R.; NOLPH, K.D. (ed.). "The textbook of peritoneal dialysis" (1ª ed.). Kluwer Academic Publishers. pp. 529-553. Dordrecht. 1994. [112] IKEDA, H. "Effects of taurine on alcohol withdrawal". Lancet. Vol. 2; pp. 509. 1977. [113] INSTITUTO NACIONAL DE LA NUTRICIÓN SALVADOR ZUBIRÁN. "Encuestas nutricionales en México. Estudios de 1963 a 1974". Instituto Nacional de la Nutrición Salvador Zubirán. División de Nutrición. Vol. 2. México, D. F. 1976. [114] INSTITUTO NACIONAL DE LA NUTRICIÓN SALVADOR ZUBIRÁN. "Encuesta urbana de alimentación y nutrición en la zona metropolitana de la ciudad de México". Instituto Nacional de la Nutrición Salvador Zubirán. México, D. F. 1995. [115] INSTITUTO DE NUTRICIÓN DE CENTRO AMÉRICA Y PANAMÁ. "Tabla de Composición de Alimentos para uso en América Latina". INCAP. Guatemala. 1968. [116] VAN WERSCH, J.W.J.; VAN MOURIK-ALDERLIESTEN, C.H.; COREMANS, A. "Comparison of markers of coagulation activation in patiens under oral anticoagulation different levels". European Journal of Clinical Chemistry and Clinical Biochemistry: Journal of the Forum of European Clinical Chemistry Societies. Vol. 30; pp. 461-466. 1992. [117] JACKSON, J.A.; HEMKEN, R.W. "Calcium and cation-anion balance effects on feed intacke, body weight gain and humoral response of dairy calves". Journal of Dairy Science. Vol. 77; pp. 1430-1436. 1994. [118] JACOBSEN, J.G. "Possible physiological functions of taurine in mammalian systems". En: CAVALLINI, D. et al. (ed.). "Trabajo presentado en el II Encuentro Internacional sobre productos naturales que contienen sulfuros de bajo peso molecular". pp. 163-172. Roma. Junio de 1979. [119] JAFFÉ, W.G.; BENGOA, J.M. "Nutrición ayer y hoy". Archivos Latinoamericanos de Nutrición. Vol. 38; pp. 429-444. 1988. [120] JIMÉNEZ, R.; FIGUERAS, J.; BOTET, F. "Neonatología" (2ª ed.). Espaxs. Barcelona. 1995. [121] JOHANSSON, G.; BACKMAN, U.; DANIELSON, B. et al. "Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide". Scandinavian Journal of Urology and Nephrology. Vol. 53; pp. 125-130. 1980. [122] JOUTAL, A.; BOUSSER, M.G.; BIOUSSE, V. et al. "A gene for familial hemiplegic migraine maps to chomosome 19". Nature Genetics. Vol. 5; pp. 40-45. 1993. [123] KALCKAR, H.M. et al. "Differential spectrophotometry of purine compounds by means of specific enximes. III Studies of the enzimes of purine metabolism". The Journal of Biological Chemistry. Vol. 167; p. 461. 1947. [124] KALLURI, R.; MEYERS, K.; MOGYOROSI, A.; MADAIO, M. P.; NEILSON, E.G. "Goodpasture syndrome involving overlap with Wegener's granlomatosis and anti-glomerular basement membrane disease". Journal of the American Society of Nephrology: JASN. Vol. 8; pp. 1795-1800. [125] KEIZER, J. "Statistical thermodynamics of nonequiblibrium processes". Springer-Verlag New York Inc. USA. 1987. [126] KHAN, O.A. "Treatment of paroxysmal symptoms in multiple sclerosis with ibuprofen". Neurology. Vol. 44; pp. 571-572. 1994. [127] KHAN, O.A.; OLEK, M.J. "Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine". Journal of Neurology, Neurosurgery, and Psychiatry. Vol. 58; pp. 235. 1995. [128] KILAV, R.; SILVER, J,; NAVEH-MANY, T. "Parathyroid hormone gene expression inhypophosphatemia rats". The Journal of Clinical Investigation. Vol. 96; pp. 327-333. 1995. [129] KINAST, H. "Aminoácidos esenciales". Centro Nacional de Medicina Biológica. Santiago de Chile. 1999. [130] KINAST, H. "Biocibernética e Hígado". Centro Nacional de Medicina Biológica. Santiago de Chile. 1999. [131] KINAST, H. "Hígado. Su especial comportamiento en la detoxificación". Centro Interamericano de Información y Estudios para el Desarrollo. Santiago de Chile. 1998. [132] KINAST, H. "Ion magnesio. Su acción en membranas celulares". Centro Nacional de Medicina Biológica. Santiago de Chile. 1999. [133] KINAST, H. "Técnicas detoxificantes". Centro Nacional de Medicina Biológica. Santiago de Chile.1999. [134] KIRINO, T.; TSUJITA, Y.; TAMURA, A. "Induced tolerance to ischemia in gervil hippocampal neurons". Journal of Cerebral Blood Flow and Metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. Vol. 11; pp. 299-307. 1991. [135] KLAHR, S.; PURKERSON, M.L. "Effects ofi dietary protein on renal function and on the progression of renal disease". The American Journal of Clinical Nutrition. Vol. 47; pp. 146-152. 1988. [136] KLEINE, N. "A method for the exact determination of trapped plasma". X Congres de la Société Européene D'Hematologie. Strasburgo. 1965. [137] KOZIELEC, T.; STAROBRAT-HERMELIN, B. "Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD)". Magnesium Research. N°. 2; vol. 10; pp. 143-148. 1997. [138] LAKE, N.; MALIK, N. "Retinal morphology in rats treated with a taurine transport antagonist". Experimental Eye Research. Vol. 44; pp. 331-346. 1987. [139] LANCASTER, T.; JONATHAN, M.; SINGER, D.E. "Stroke prevention in atrial fibrilation". British Medical Journal. Clinical Research Ed. Vol. 314; pp. 1563-1564. 1997. [140] LATORRE, R.; LÓPEZ-BARNEO, J.; BEZANILLA, F.; LLINÁS, R. "Biofísica y fisiología celular". Universidad de Sevilla (Secretariado de publicaciones). Sevilla. 1996. [141] LAYNE, E. "Spectrophotometryc and turbidimetric methods for measuring proteins". Methods in Encymologic. Vol. 3; pp. 447. 1957. [142] LIMA, L.; CRUZ, T.; POUSADA, J.C.; RODRÍGUEZ, L.E.; BARBOSA, K.; CANGUCU, V. "The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes". Diabetes Care. N°5; vol. 21; pp. 682-686. 1998. [143] LIPTON, S.A.; ROSENBERG, P.A. The New England Journal of Medicine. Vol. 330; p. 613. 1994. [144] LOPEZ-HILKER, S.; DUSSO, A.; RAPP, N.; MARTIN, K.; SLATOPOLSKY, E. "Phosphorus restriction reverses secondary hyperparthyroidism in chronic renal failure independent of changes in calcium and 1,25 dihydroxicholecalciferol". The American Journal of Physiology. Vol. 259; pp. 432-437. 1990. [145] LORRAIN, E.; LEVITT, K.; STANLEY, C. "Disorders of glucose and others sugars". En: SPITZER, A.R. (ed.). "Intensive care of the fetus and neonate". Mosby. San Luís, California. 1996. [146] LUBAS, G.; CONTINANZA, R. "Recent advances in our understanding of the immunohaematological characteristics of cats and their clinical application". Eur J Comp Anim Pract. N°1; vol. 5; pp. 47-54. 1995. [147] MANGAT, H.S.; D'SOUZA, G.A.; JACOB, M.S. "Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: a clinical trial". European Respiratory Journal. N°2; vol. 12; pp. 341-344. 1998. [148] MANTOVANI, J.; DE VIVIO, D.C. "Effects of taurine on seizures and growth hormone release in epileptic patients". Archives of Neurology. Vol. 36; pp. 672-674. 1979. [149] MARINCOVICH, D.I.; MARINCOVICH, R.I.; DURAN, M.C.; HAZBUN, J. "Ingesta alimentaria de escolares rurales de la Región Metropolitana de Chile. Un estudio comparativo". Archivos Latinoamericanos de Nutrición Vol. 42; pp. 374-388. 1992. [150] MARONGIU, F.A. "Untersuchungen über mineralbstímmungen in erythrozyten bei gesunden und hypertonikern". Tesis Doctoral. Universidad de Friburgo. Friburgo. 1966. [151] MARRUECOS, L.; NOGUÉ, S.; NOLLA, J. (ed.). "Toxicología clínica". Springer-Verlag Ibérica. Barcelona. 1993. [152] MARTÍN, A.; GARCÍA-ALIX, A.; PASCUAL, D. et al. "La interleucina 6 en el líquido cefalorraquídeo después de la asfixia perinatal se encuentra relacionada con las manifestaciones neurológicas precoces y tardías". Pedíatrics. Vol. 44; pp. 345-351. 1997. [153] MARTÍNEZ-ORGADO, J.; RUIZ, M.; CANO, M.V. et al. "Metabolismo neuronal en el daño hipóxico-isquémico. Isquemia y reperfusión cerebral". Revista Latinoamericana de Neonatología (RELAN). Vol. 1; sup.1; p. 235. [154] MATSUZAKI, Y. et al. "Is taurine effective for treatment of painful muscle cramps in liver cirrhosis?". The American Journal of Gastroenterology. Vol. 88; pp. 1466-1467. 1993. [155] MATTHEWS, G. "Toxic gases". Postgraduate Medical Journal. Vol. 65; pp. 224-232. 1989. [156] MCNEIL, J.J.; KRUM, H. "Cardiovascular disorders". En: SPEIGHT, T.M.; HOLFORD, N.H.G. (ed.). "Avery's drug treatment" (4ª ed.). Adis International. pp. 809-896. Auckland. 1997. [157] MELDRUM, B.; GARTHWAITE, J. "Trends in pharmacological sciences". Elsevier Science. Vol. 11; p. 379. 1990. [158] MENCHÚ, M.T. "Revisión de la metodologías aplicadas en estudios sobre consumo de alimentos". INCAP. Guatemala. 1992. [159] MITCHELL, C.A.; CARROLL, P.A. "Acute toxicity of inhaled gases and particulates". The Medical Journal of Australia. Vol. 150; pp. 717-719. 1998. [160] MOLLEM, E.; KILAV, R.; SILVER, J.; NEVEH-MANY, T. "RNA-protein binding andpostranscrptional regulation of parathyroid gene expression by calcium and phosphate". The Journal of Biological Chemistry. Vol. 9; pp. 5253-5259. 1998. [161] MONGIN, P. "Recent advances in anion-cation balance in poultry. In recent developments in poultry nutrition". Butterworths. Londres. 1989. [162] MONTERO, F.J. "La hidroxicobalamina en el tratamiento de la intoxicación conjunta por monóxido de carbono y cianuro". Medicina Clínica. Vol. 110; pp. 558-559. 1998. [163] MOOL, S.; ORTEL, T.L. "Monitoring warfarin therapy in patients with lupus anticoagulants". Annals of Internal Medicine. Vol. 127; pp. 177-185. 1997. [164] NATIONAL INSTITUTE OF HEALTH. "Optimal calcium intake". NIH Consensus Statement. N°4; vol. 12; pp. 1-6. 1994. [165] NAVARRO, J.L.; CÉSAR, J.M.; GARCÍA, L.J.; PARDO, A.; AVELLO, A. G. et al. "Control de la anticoagulación oral en sangre capilar". Revista Sangre. N°4; vol. 39; pp. 257-260. 1994. [166] NAVEH-MANY, T.; RAHAMIMOV, R.; LIVNI, N.; SILVER, J. "Parathyroid cell proliferation in normal and chronic renal failure rats: the effects of calcium, phosphate and vitamin D". The Journal of Clinical Investigation. Vol. 96; pp. 1786-1793. 1995. [167] NEMOTO, E.M. "Brain ischemia". En: LAJTHA, A. (ed.). "Handbook of neurochemistry". Plenum Press. Vol. 9. Nueva York. 1985. [168] NETSELL, R.; KENT, R.D. "Paroxysmal ataxic dysarthria". The Journal of Speech and Hearing Disorders. Vol. 41; pp. 93-109. 1976. [169] NEURINGER, M.; STURMAN, J. "Visual acuity loss in rhesus monkey infants fed a taurine-free human infant formula". Journal of Neuroscience Research. Vol. 18; pp. 597-601. 1987. [170] NIELSEN, P.K.; FELDT-RASMUSEN, U.; OLGARD, K. "A direct effect of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells". Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. Vol. 11; pp. 1762-1768. 1996. [171] NORDSTROM, C.H.; SIESJÖ, B.K. "Neurochemical determinant of ischemic cell damage". En: WEINSTEIN, P.R.; FADEN, A.I. (ed.). "Protection of the brain from ischemia". Williams and Wilkins. Baltimore. 1990. [172] NORMAN, A.W. "Calcium and phosphorus absorption". En: LAWSON, D.E. (ed.). "Vitamin D". Academic Press. pp. 93-132. Londres. 1978. [173] O'DONOGHUE, D.J.; SHORT, C.D.; BRENCHLEY, P.E.C.; LAWLER, W.; BALLARDIE, F.W. "Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease". Clinical Nephrology. Vol. 3; pp. 251-255. 1989. [174] OETZEL, G.R.; OLSON, J.D.; CURTIS, C.R.; FETTMAN, M.J. "Ammonium chloride and ammonium sulfate for prevention of paturient paresis in dairy cows". Journal of Dairy Science. Vol. 71; pp. 3302-3309. 1988. [175] OLNEY, J.W. et al. "Science". Vol. 254; p. 1515. 1991. [176] O'MALLEY, M. "Clinical evaluation of pesticide exposure and poisonings". Lancet. Vol. 349; pp. 1161-1166. 1997. [177] OPHOFF, R.A.; TERWINDT, G.M.; VERGOUWE, M.N. et al. "Familial hemiplegic migraine and episodic ataxia type 2 are caused by mutations in the Ca2+ channel gene CACNL1A4". Cell. Vol. 1; pp. 1534-1552. 1996. [178] OSTERMANN, P.O.; WESTERBERG, C.E. "Paroxysmal attacks in multiple sclerosis". Brain. Vol. 98; pp. 189-202. 1975. [179] PAK, C.Y.C.; BRITTON, F.; PETERSON, R.; WARD, D.; NORTHCUTT, C.; BRESLAU, N.A. et al. "Ambulatory evaluation of nephrolitiasis: classification, clinical presentation and diagnostic criteria". The American Journal of Clinical Nutrition. Vol. 69; pp. 19-21. 1980. [180] PAK, C.Y.C.; SAKHAEE, K.; CROWTHER, C.; BRINKLEY, L. "Dietary management of idiopathic calcium urolithiasis". British Journal of Urology. Vol. 131; pp. 850-852. 1984. [181] PALACIOS, A.J.; MALANCO, C.F.L. "Análisis del proceso de separación con membranas como un fenómeno de transporte". Educación Química, UNAM. México. 1993. [182] PARK, B.K.; PIRMOHAMED, M.; KITTERINGHAM, N.R. "Idiosyncratic drug reactions: a mechanistic evaluation of risk factors". British Journal of Clinical Pharmacology. Vol. 34; pp. 377-395. 1992. [183] PASCUAL, J.; CASTRO, M.E. "Fisiopatología de la migraña". Neurología. Vol. 13; pp. 29-32. 1998. [184] PECES, R.; RODRÍGUEZ, M.; POBES, A.; SECO, M. "Sequential development of pulmonary hemorrhage with MPO-ANCA complicating anti-glomerular basement membrana antibody-medíated glomerulonehritis". American Journal of Kidney Diseases: the official journal of the National Kidney Foundation. Vol. 35; pp. 954-957. 2000. [185] PENGO, V.; ZASSO, A.; BARBERO, F.; GARELLI, E.; BIASIOLO, A. "Low intensity warfarin therapy". Haematologica. N°6; vol. 82; pp. 710-712. 1997. [186] PICKERING, G.W. "Hypertension, causes, consequences and management". J&A Churcill. Londres. 1970. [187] PIESSE, J.W. "Nutritional factors in the premenstrual syndrome". Int Clin Nutr Rev. Vol. 4; pp. 54-81. 1984. [188] PIKE, R.L.; BROWN, M.L. "Nutrition: an integrated approach" (2ª ed.). John Wiley & Sons. Nueva York. 1975. [189] PIRMOHAMED, M.; KITTERINGHAM, N.R.; PARK, B.K. "The role of active metabolites in drug toxicity". Drug safety: an international journal of medical toxicology and drug experience. Vol. 11; pp. 114-144. 1994. [190] PIRMOHAMED, M.; MADDEN, S.; PARK, B.K. "Idiosyncratic drug reactions: metabolic bioactivation as a pathogenic mechanism". Clinical pharmacokinetics. N°3; vol. 31; pp. 215-230. 1996. [191] POCKET, R.; DONATO, R.; HAIECH, J.; HEIZMANN, C.W.; GERKE, V. "The molecular basis of calcium action in biology and medicine". Kluwer Academic Press. Dordrecht. 2000. [192] POLLER, L. "European concert action on anticoagulation (ECAA)". Haemostasis. Vol. 26; sup. 4; pp. 266-268. 1996. [193] POWER, C.; BARKER, D.J.P.; BLACKLOCK, N.J. "Incidence of renal stones in 18 british towns". British Journal of Urology. Vol. 59; pp. 105-110. 1987. [194] PULSINELLI, W. "Selective neuronal vulnerability: morphological and molecular characteristics". En: KOGURE, K.; HOSSMANN, K.A.; SIESJÖ B.K.; W,ELSH F.A. (ed.). "Molecular mechanisms of brain damage, progress in brain research". Elseviere. Vol. 63. Amsterdam. 1985. [195] QUICK, A.J.; STANLEY, M.; BRANCROFT, F.W. "A study of the coagulation defect in the hemophilia and jaundice". The American Journal of the Medical Sciences. Vol. 190; p. 501. 1935. [196] RAWLINS, M.D.; THOMPSON, J.W. "Pathogenesis of adverse drug reactions". En: DAVIES, D.M. (ed.). "Textbook of adverse drug reactions" Oxford University Press. p.44. Oxford. 1977. [197] REGINALD, C.; TSANG, M.D. "Calcium, phosphorus, and magnesium metabolism". En: POLIN, R.A.; FOX, W.W. (ed.). "Fetal and neonatal physiology". W.B. Saunders. Filadelfia. 1996. [198] REIVICH, M. "Pathophysiology of cerebral ischemia". En: HARRISON, M.J.G.; DYKEN, M.L. (ed.). "Cerebral vascular disease". Butherworths. Londres. 1983. [199] REJAS LÓPEZ, J.; REJAS GARCÍA, F. "Transfusión sanguínea". En: REJAS LÓPEZ, J.; PRIETO MONTAÑA, F. "Fluidoterapia en clínica veterinaria". Universidad de León. pp. 171-186. León, España. 1996. [200] RENTKO, V.T.; COTTER, S.M. "Tratamiento mediante transfusiones: análogos de los eritrocitos y autotransfusión". En: KIRK, R.W.; BONAGURA, J.D. (ed.). "Terapéutica veterinaria de pequeños animales XI". Interamericana McGraw-Hill. pp. 116-118. Madrid. 1994. [201] RESNICK, M.I.; BENSON, M.A. "Manual de problemas clínicos en urología". Salvat Editores. Barcelona. 1990. [202] RÍO, J.; COLÍN, A.; SALVADOR, F.; TINTORÉ, M.; VIGUERA, M. L.; MONTALBÁN, J. et al. "Periflebitis retiniana en la esclerosis múltiple. Estudio prospectivo". Neurología. Vol. 8; pp. 252-255. 1993. [203] ROBBINS. "Manual de Patología Estructural y Funcional" (6ª ed.). Editorial McGraw-Hill. Barcelona. 2000. [204] ROBBINS. "Patología humana (kumar)" (6ª ed.). Editorial McGraw-Hill. Barcelona. 1998. [205] ROMO, G. A. et al. "Some blood minerals and hormones in cows fed variable mineral levels and ionic balance". Journal of Dairy Science. Vol. 74; pp. 3068-3077. 1991. [206] ROQUER, J.; VALLECILLO, G.; PALOMERAS, E.; POU, A. "Manifestaciones paroxísticas en la esclerosis múltiple". Neurología. Vol. 12; pp. 369-370. 1997. [207] RORISON, D.G.; MCPHERSON, S.J. "Acute toxic inhalations". Emergency Medicine Clinics of North America. Vol. 10; pp. 409-435. 1992. [208] ROSEBBERG, W.; DONALD, A. "Evidence based medicine. An approach to clinical problem solving". Clinical Research Ed. British Medical Journal. Vol. 310; pp. 1122-1126. 1995. [209] ROSENBERG, G.A. "Brain fluids and metabolism". Oxford University Press. Oxford. 1990. [210] ROTHMAN, S.M.; OLNEY, L.W. "Glutamate and pathophysiolgy of hipoxic-ischemia brain damage". Annals of Neurology. Vol. 19; pp. 105-111. 1986. [211] RUBIO, S.; GARCÍA, M.L. "Intoxicación por monóxido de carbono". Medicina Clínica. Vol. 108; pp. 776-778. 1997. [212] RUFO, M.; PALENCIA, R. "Encefalopatía hipóxico-isquémica del recién nacido a término. Recientes avances, marcadores de hipoxia y opciones terapéuticas". Revista de Neurología. Vol. 31; pp. 617-623. 2000. [213] SÁNCHEZ, W.K.; BEEDE, D.K.; DELORENZO, M.A. "Macromineral element interrelationships and lactational performance: empirical models from a large data set". Journal of Dairy Science. Vol. 77; pp. 3096-3110. 1994. [214] SAOUR, J.N.; SIECK, J.O.; MAMO, L.A.R.; GALLUS, A.S. "Trial of different intensities of anticoagulantion in patientes with prosthetic heart valves". The New England Journal of Medicine. Vol. 322; pp. 428-432. 1990. [215] SAVIGE, J.; DAVIES, D.; FALK, R.J.; JENNETTE, C.; WIIK, A. "Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features". Kidney International. Vol. 57; pp. 846-62. 2000. [216] SBRIMPTON, R. "Food consumption and dietary adequacy according to income in 1200 families, Manaus, Amazonas, Brazil". Archivos Latinoamericanos de Nutrición. Vol. 34; pp. 615-629. [217] SCHWITZGEBEL, V.M.; GITELMAN, S.E. "Neonatal hyperinsulinism". Clinics in Perinatology. Vol. 4; p. 1015. 1998. [218] SERRANO-CASTRO, P.J.; SÁNCHEZ-ALVAREZ, J.C.; GARCÍA-GÓMEZ, T. "Esclerois temporal mesial (II): manifestaciones clínicas y estudios complementarios". Revista de Neurología. Vol. 26; pp. 592-597. 1998. [219] SIDO, T.C.; SORIMACHI, H.; SUZUKI, K. "The FASEB journal: official publication of the Federation of American Societies for Experimental Biology". Vol. 8; p. 814. 1994. [220] SIESJÖ, B.K. "Cerebral circulation and metabolism". Journal of Neurosurgery. Vol. 60; p. 883-908. 1984. [221] SIESJÖ, B.K. "Historical overview, calcium, ischemia and death of brain cells". Annals of the New York Academy of Sciences. Vol. 522; p. 638-661. 1988. [222] SIESJÖ, B.K. "Mechanisms of ischemic brain damage". Critical Care Medicine. Vol 16; pp. 954-1218. 1988. [223] SINGER, M.M. et al. "Red blood cell potassium. Therapeutic implications". JAMA: the Journal of the American Medical Association. Vol. 187; p. 24. 1964. [224] SLATOPOLSKY, E.; FINCH, J.; DENDA, M.; RITTER, C.; ZHONG, A.; DUSSO, A. et al. "Phosphate restriction prevents parathyroid cell growth in uremic rats. High phosphate directly stimulates PTH secretion in vitro". The Journal of Clinical Investigation. Vol. 97; pp. 2534-2540. 1996. [225] SLATOPOLSKY, E.; WEERTS, C.; LÓPEZ-HILKER, S. et al. "Calcium carbonate as a phosphate binder in patient with chronic renal failure undergoing dialysis". The New England Journal of Medicine. Vol. 315; pp. 157-161. 1986. [226] SMITH, L.J. et al. "Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis". American Journal of Diseases of Children. Vol. 145; pp. 1401-1404. [227] SOKOLOFF, L. "Circulation and energy metabolism of the brain". En: SIEGEL, G.; AGRANOFF, B.; ALVERS, R.W.; MOLINOFF, P. (ed.). "Basic Neurochemistry" (4ª ed.). Raven Press. Nueva York. 1989. [228] SOMMARIVA, M.; RIGATTI, P.; VIOLA, M.R. "Profilassi della recidiva della litiasi urinaria: acque minerales ad alto o basso contenuto di calcio?". Minerva Médica. Vol. 78; pp. 1823-1829. 1987. [229] STEWART, P.A. "Modern quantitative acid-base chemistry". Canadian Journal of Physiology and Pharmacology. Vol. 61; pp. 1444-1461. 1983. [230] STONE, M.S.; COTTER, S.M. "Consejos prácticos para las transfusiones". En: KIRK, R.W.; BONAGURA, J.D. (ed.). "Terapéutica veterinaria de pequeños animales XI". Interamericana McGraw-Hill. pp. 525-529. Madrid. 1994. [231] STREWLER, G.J.; ROSENBLATT, M. "Mineral metabolism". En: FELING P.; BAXTER, J.D.; FROHMAN, L.A. (ed.). "Endocrinology and metabolism". McGraw-Hill, Incorporated. pp. 1407-1516. Nueva York. 1995. [232] SUBCOMMITTEE ON THE TENTH EDITION OF THE RECOMMENDED DIETARY ALLOWANCES; FOOD AND NUTRITION BOARD; COMMISSION ON LIFE SCIENCES; NATIONAL RESEARCH COUNCIL. "Recommended dietary allowances" (10ª ed.). National Academy Press. Washington, D. C. 1991. [233] SWANSON, D.R. "Migraine and magnesium: eleven neglected connections". Perspectives in Biology and Medicine. Vol. 31; pp. 526-557. 1988. [234] TAKAHASHI, F.; FINCH, J.; BROWN, A.; SLATOPOLSKY, E. "The effects of low phosphorus diet on the secretion of PTH in established diffuse para- thyroid hyperplasia". Journal of the American Society of Nephrology. Vol. 8; p. 580. 1997. [235] TALBERT, R.L. "Hyperlipidemia". En: DIPIRO, J.T.; TALBERT, R.L.; HAYES, P.E.; YEE, G.C.; ATZKE, G.R.; POSEY, L.M. (ed.). "Pharmacotherapy. A pathophysiologic approach". Elsevier Science Publishing. pp. 357-387. Nueva York. 1992. [236] TANAGHO, E.A.; MCANINCH, J.W. "Urología general de Smith" (5º ed.). El Manual Moderno. México. 1997. [237] TIBBLES, P.M.; PERROTTA, P.L. "Treatment of carbon monoxide poisoning: a critical review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen". Annals of Emergency Medicine. Vol. 24; pp. 269-276. 1994. [238] TOMASZEWSKI, C. "Carbon monoxide poisoning. Early awareness and intervention can save lives". Postgraduate Medicine. Vol. 105; pp. 39-48. 1999. [239] TORRES, A.; LORENZO, V.; CANNATA, J. "Osteodistrofia renal". En: LORENZO, V.; TORRES, A.; HERNÁNDEZ, D.; AYÚS, J.C. (ed.). "Manual de nefrología clínica, diálisis y trasplante renal" (1ª ed.). Harcourt Brace. pp. 595-614. Madrid. 1998. [240] TOUNIAN, P.; SALAUN, J.F.; BENSMAN, A. et al. "Energy balance in children and young adults receving haemodíalysis for chronic renal failure". Clinical Nutrition. N°6; Vol. 14; pp. 341-347. 1995. [241] TOURNIER, E.; JOUTEL, A.; MELKI, J. et al. "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12". Nature Genetics. Vol. 3; pp. 256-259. 1993. [242] TUCKER, W.B. et al. "Influence of dietary cation-anion balance during the dry period on the occurrence of parturient paresis in cows fed excess calcium". Journal of Animal Science. Vol. 70; pp. 1238-1250. 1992. [243] TUCKER, W.B. et al. "Role of sulfur and chloride in the dietary cation-anion balance equation for lactating dairy cattle". Journal of Animal Science. Vol. 69; pp. 1205-1213. 1991. [244] TUCKER, W.B.; HARRISON, G.A.; HEMKEN, R.W. "Influence of dietary cation-anion balance on milk, blood, urine and rumen fluid in lactating dairy cattle". Journal of Dairy Science. Vol. 71; pp. 346-354. 1988. [245] TURPIE, A.G.G.; GUNSTENSEN, J.; HIRSH, J.; NELSON, H.; GENT, M. "Randomisierter vergleich zweier dosierungsstärken zur oralen antikoagulantientherapie nach bioklappenersatz". Lancet (Ed. Alemana). Vol. 2; pp. 587-590. 1988. [246] VAN DEN BESSELAAR, A.M.H.P. "Precision and accuracy of the international normalized ratio in oral anticoagulant control". Haemostasis. Vol. 26; sup. 4; pp. 248-265. 1996. [247] VERMEER, C. "Effects of vitamine K and oral anticoagulants on calcium metabolism". Simposium Internacional sobre la utilización de los anticoagulantes orales en Europa. F.M. Gráfico. pp.19-290. Barcelona. Noviembre de 1993. [248] VINTON, E.N. "Taurine concentrations in plasma and blood cells of patients undergoing long-term parenteral nutrition". The American Journal of Clinical Nutrition. Vol. 44; pp. 398-404. 1986. [249] WADELL, W.J. "Bestimmung des eisweiss durch UV-absorption". The Journal of Laboratory and Clinical Medicine. Vol. 48; p. 311. 1956. [250] WALLACE, D.R.; DAWSON, R. "Decreased plasma taurine in aged rats". Gerontology. Vol. 36; pp. 19-27. 1990. [251] WANG, K.K.W.; VILLALOBO, A.; ROUFOGALIS, B.D. "The Biochemical Journal". Vol. 262; p. 693. 1989. [252] WANG, K.K.W.; YUEN, P.W. "Calpain inhibition: an overview of its therapeutic potential". Technical Tips Online. Vol 15; p. 412. 1994. [253] WANG, Q.; PALNITKAR, S.; PARFITT, A.M. "Parathyroid cell proliferation in the rat: effect of age and phos-phate administration and recovery". Endocrinology. Vol. 137; pp. 4558-4562. 1996. [254] WATERMAN, D.F. et al. "Role of magnesium in dietary cation-anion balance of ruminants". Journal of Dairy Science. Vol. 74; pp. 1866-1873. 1991. [255] WATSON, J.D. "Molecular biology of the gene" (3ª ed.). W.A. Benjamín Inc. Editorial Omega. México. 1976. [256] WATTS, B.M.; YLIMAKI, G.L.; JEFFERY, L.E.; ELÍAS, L.G. "Métodos sensoriales básicos para la evaluación de alimentos". Centro Internacional de Investigaciones para el Desarrollo. Ottawa. 1992. [257] WEAVER, L.K. "Carbon monoxide poisoning". Critical Care Clinics. Vol. 105; pp. 39-48. 1999. [258] WEIBERT, R.T.; LEE, D.T.; KAYSER, S.R.; RAPAPORT, S.I. "Correction of excesive anticoagulation with low-dose oral vitamine K1". Annals of Internal Medicine. Vol. 125; pp. 959-962. 1997. [259] WEISS, S.M.; LAKSHMINARAYAN, S. "Acute inhalation injury". Clinics in Chest Medicine. Vol. 15; pp. 103-115. 1994. [260] WEISS, T.F.; MIELCZAREK, E.V. "Cellular biophysics". The MIT Press. Vol. 1 y 2. Massachussets. 1996. [261] WEST, J.W.; MULLINIX, B.G.; SANDIFER, T.G. "Changing dietary electrolyte balance for dairy cows in cool and hot environments". Journal of Dairy Science. Vol. 74; pp. 1662-1674. 1991. [262] WHITE, J.R.; CAMPBELL, R.K. "Magnesium and diabetes: a review". The Annals of Pharmacotherapy. Vol. 27; pp. 775-780. 1993. [263] WOLF, P.; ASSMUS, H. "Paroxysmale dysarthrie und ataxie: ein pathognomisches anfallsyndrom bei multipler sclerose". Journal of Neurology. Vol. 208; pp. 27-38. 1974. [264] YAMANAKA, Y. et al. "Stimulation of chenodeoxycholic acid excretion in hyper cholesterolemic mice by dietary taurine". Journal of Nutritional Science and Vitaminology. Vol. 32; pp. 287-296. 1986. [265] YAMREUDEEWONG, W.; JOHNSOSN, J.V.; CASSIDY, T.G.; BERG, J.T. "Comparison of two methods for INR determination in a pharmacist-based oral anticoagulant". Clinical Pharmacology and Therapeutics. N°6, vol. 16; pp. 1159-1165. 1996. [266] YI, H.; FUKAGAWA, M.; YAMATO, H.; KUMAGAI, M.; WATANABE, T.; KUROKAWA, K. "Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus". Nephron. Vol. 70; pp. 242-248. 1995. [267] YUDD, M.; GOLDBLAT, M.; HERVAS, J.; LLACH, F. "Two and a half year follow-up of intravenous calcitriol therapy for severe secondary hyperparathyroidism: hyperphosphatemia and hypercalcemia". Journal of the American Society of Nephrology. Vol. 8; p. 556. 1997. [268] ZENI, S.; DE PORTELA, M. L. "Estado nutricional con respecto al calcio en Argentina". Archivos Latinoamericanos de Nutrición. Vol. 38; pp. 209-218. 1988. [269] ZENI, S.; DE PORTELA, M.L.; MORASSO, M.C.; RÍO, M.E. "Calcio/creatinina en orina basal en relación a la ingestión de calcio y al estado nutricional en menores de tres años". Archivos Latinoamericanos de Nutrición. Vol. 34; pp. 35-45. 1984. [270] ZENTELLA, M.; DÍAZ-CRUZ, A.; GUINZBERG, P.R.; PIÑA, E. "Effect of adenosine and inosine on gluconeogenesis from lactate in isolated hepatocytes". Life Sciences. Vol. 45; pp. 2269-2274. 1989. [271] ZUCKER, S.; CATHEY, M.H.; SOX, P.J.; HALL, E.C. "Standardization of laboratory test for controling anticoagulant therapy". American Journal of Clinical Pathology. Vol.53; p.384. 1970. |
